# Single Ascending Dose and Multiple Ascending Dose Study of AVR-48

> **NCT06847698** · PHASE1 · NOT_YET_RECRUITING · sponsor: **AyuVis Research, Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Safety Issues
- Tolerability
- Pharmacokinetics
- Pharmacodynamics

## Interventions

- **DRUG:** AVR-48
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06847698
- **Lead sponsor:** AyuVis Research, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2025-10
- **Final completion:** 2025-11
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06847698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06847698, "Single Ascending Dose and Multiple Ascending Dose Study of AVR-48". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06847698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*